Pfizer eyes approval for 95% effective COVID-19 vaccine 'within days'
Pfizer and BioNTech are expected to produce up to 50 million doses globally in 2020 and up to 1.3 billion doses by the end of 2021. |!| Murfreesboro
Pfizer and BioNTech are expected to produce up to 50 million doses globally in 2020 and up to 1.3 billion doses by the end of 2021. |!| Murfreesboro